FDA clears AngioScore catheter

05/2/2008 | American City Business Journals

The FDA has granted AngioScore approval to market its AngioSculpt PTA catheter, which can be used for balloon dilatation of lesions in various arteries and to treat certain obstructive lesions. The clearance allows the company "to address several of the largest and fastest growing segments of the peripheral artery disease market in the U.S.," CEO Thomas R. Trotter said.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR
Director of Operations - GBS
Mayo Clinic
Rochester, MN